Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kobe C Yuen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bio-Protocol|August 30, 2021
Measurement of RNA-induced PKR Activation <i>in vitro</i>Kobe C Yuen
Plos Genetics|January 26, 2018
Taking cohesin and condensin in contextKobe C Yuen, Jennifer L Gerton
Science Advances|July 11, 2017
Condensin II is anchored by TFIIIC and H3K4me3 in the mammalian genome and supports the expression of active dense gene clustersKobe C Yuen, Brian D Slaughter, Jennifer L Gerton
Cell Reports|January 4, 2016
NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKRKobe C Yuen, Baoshan Xu, Ian D Krantz, et al.
Developmental Biology|March 22, 2015
Mef2c-F10N enhancer driven β-galactosidase (LacZ) and Cre recombinase mice facilitate analyses of gene function and lineage fate in neural crest cellsKazushi Aoto, Lisa L Sandell, Naomi E Butler Tjaden, et al.
The Prostate|April 18, 2022
Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimensKobe C Yuen, Ben Tran, Angelyn Anton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate CancerLawrence Fong, Michael J Morris, Oliver Sartor, et al.
Cancer Immunology Research|April 24, 2020
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate CancerMarie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, et al.
Nature Medicine|January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Nature|June 17, 2021
ctDNA guiding adjuvant immunotherapy in urothelial carcinomaThomas Powles, Zoe June Assaf, Nicole Davarpanah, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bio-Protocol|August 30, 2021
Measurement of RNA-induced PKR Activation <i>in vitro</i>Kobe C Yuen
Plos Genetics|January 26, 2018
Taking cohesin and condensin in contextKobe C Yuen, Jennifer L Gerton
Science Advances|July 11, 2017
Condensin II is anchored by TFIIIC and H3K4me3 in the mammalian genome and supports the expression of active dense gene clustersKobe C Yuen, Brian D Slaughter, Jennifer L Gerton
Cell Reports|January 4, 2016
NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKRKobe C Yuen, Baoshan Xu, Ian D Krantz, et al.
Developmental Biology|March 22, 2015
Mef2c-F10N enhancer driven β-galactosidase (LacZ) and Cre recombinase mice facilitate analyses of gene function and lineage fate in neural crest cellsKazushi Aoto, Lisa L Sandell, Naomi E Butler Tjaden, et al.
The Prostate|April 18, 2022
Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimensKobe C Yuen, Ben Tran, Angelyn Anton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate CancerLawrence Fong, Michael J Morris, Oliver Sartor, et al.
Cancer Immunology Research|April 24, 2020
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate CancerMarie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, et al.
Nature Medicine|January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Nature|June 17, 2021
ctDNA guiding adjuvant immunotherapy in urothelial carcinomaThomas Powles, Zoe June Assaf, Nicole Davarpanah, et al.
Pageof 2